The US Suboxone market is a key treatment option for opioid addiction in the country. Suboxone (buprenorphine and naloxone) is used to treat opioid use disorder by relieving cravings and withdrawal symptoms without producing the euphoric effects that are associated with misuse. It comes in the form of sublingual film or tablet.
The US Suboxone market has been one of high demand owing to the high prevalence of opioid addiction in the country. According to the National Institute of Drug Abuse, over 2 million Americans suffer from prescription opioid and heroin use disorders. Suboxone provides safer and effective treatment to overcome opioid addiction and prevent overdose deaths.
The United States of America Suboxone Market is estimated to be valued at US$ 2,285.5 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the US Suboxone market are Indivior PLC., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC., Mylan N.V., Novartis AG, Teva Pharmaceutical Industries Ltd., Mallinckrodt, Lannett Co Inc., Sun Pharmaceutical Industries Ltd., and Alkem Labs. Indivior PLC is the leading player with over 80% market share owing to its branded Suboxone film and tablet formulation. Teva and Dr Reddy's entered the market with generic versions in late 2019, capturing market share from Indivior.
The US Suboxone market has seen rising demand driven by high prevalence of opioid addiction. According to CDC, over 47,000 Americans died due to opioid overdose in 2018 alone. Suboxone provides safer treatment option to manage withdrawal symptoms and prevent relapses and opioid overdoses.
Technological developments include the introduction of Suboxone sublingual film that delivers buprenorphine at a consistent dose. This improved delivery method ensures patient safety and compliance to treatment. Long acting injectable and implant versions are under development that can further improve treatment effectiveness through sustained drug release.
Market Trends
Development of generic formulations of Suboxone has increased treatment access and affordability. Leading generic players Teva, Dr Reddy’s, Lannett, and Amneal captured significant market share with affordable products in 2020. Further patent expiries in 2023 will intensify generic competition.
Branded drug maker Indivior is facing loss of market share and revenue with generic entry. It launched authorized generic versions of its Suboxone film to maintain segment share.
Market Opportunities
Rising opioid abuse prevalence indicates increased treatment needs over the forecast period. This will drive the demand for generics as well as branded Suboxone products.
Approval of long acting injectable and implant versions can enhance patient compliance by reducing dosing frequency. Such innovative formulations present high growth opportunities for players.
Impact Of COVID-19 On The United States Of America Suboxone Market
The COVID-19 pandemic has negatively impacted the United States of America Suboxone market. The lockdowns imposed by various states resulted in disruption of supply chains leading to shortage of raw materials for manufacturing. Moreover, restrictions on non-essential medical procedures, including addiction treatment centers getting temporarily closed, declined the prescription volumes and patient access to Suboxone in 2020. However, telemedicine saw increased adoption as medical practitioners started remote consultation and prescription delivery to maintain treatment continuity. Post-COVID, the market is expected to witness steady growth driven by resumption of normal activities. Investments are being made by key players to expand production capacities and ensure stable supply. Reimbursement policies are also being revisited to improve affordability and access for patients in rural areas.
Geographical Regions With High Market Concentration
In terms of value, the Northeast region accounts for over 35% share of the total United States of America Suboxone market. States like New York, Pennsylvania, New Jersey have high prevalence of opioid addiction and maintain established treatment infrastructure. The midwestern region is another concentrated market with states like Ohio, Illinois and Michigan reporting large patient volumes. These regions have witnessed steady growth pre-COVID due to conducive reimbursement schemes and support from state health departments for expanding addiction care centers.
Fastest Growing Geographical Region
The Southern region represents the fastest growing market for Suboxone in the United States. States like Florida, Texas, North Carolina and Georgia are diversifying treatment options and improving awareness. The comparatively lower treatment cost has attracted patients from other states as well. Telehealth programs launched post-COVID have further propelled growth. Partnerships between local health departments and key industry players is also fueling regional market expansion through comprehensive care programs.
Get more insights on this topic: https://www.pressreleasebulletin.com/united-states-of-america-suboxone-market-is-estimated-to-witness-high-growth-owing-to-high-prevalence-of-opioid-abuse-disorders/
Author Bio
Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups. (LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
What Are The Key Data Covered In This United States Of America Suboxone Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the United States Of America Suboxone 's growth between 2024 and 2031.
:- Accurate calculation of the size of the United States Of America Suboxone and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- United States Of America Suboxone Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of United States Of America Suboxone vendors
FAQ’s
Q.1 What are the main factors influencing the United States Of America Suboxone ?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top United States Of America Suboxone companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the United States Of America Suboxone ’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
Comments
0 comment